Charles River Laboratories International, Inc. has entered into an agreement to acquire 75% of Vital River, a commercial provider of research models and related services in China, for approximately $27 million. Charles River also has an option to acquire the remaining 25% of Vital River in the future. With this acquisition, Charles River will provide research models and associated services to the emerging China market for drug discovery and development. The acquisition is expected to close in 1...